Pauline T Mayer serves as the President of PTM Healthcare Marketing, Inc. and is the Editor of Medical Device News Magazine, bringing decades of specialized expertise to the intersection of healthcare communication, strategic branding, and industry advocacy. Her background spans the full spectrum of medical public relations and healthcare marketing, with a particular emphasis on elevating emerging companies and amplifying the voices of innovators shaping the future of medicine.

Throughout her career, Ms. Mayer has distinguished herself as a trusted partner to medical device startups, biotech innovators, medical specialists, non‑profit organizations, and major medical conferences. Her strengths lie in designing and executing public relations campaigns that not only generate visibility but also build credibility in highly regulated, scientifically complex markets. She has guided organizations through product launches, clinical milestone announcements, fundraising visibility efforts, and thought‑leadership positioning—always with a keen understanding of the nuances that define the healthcare landscape.

Ms. Mayer has also played a pivotal role in advocacy communications, helping non‑profits and professional groups raise public awareness around critical regulatory, reimbursement, and patient‑access issues. Her work has supported campaigns that influence policy discussions, mobilize stakeholders, and educate the public on emerging healthcare challenges.

Over the years, she has leveraged top‑tier wire services, negotiated premium placements in leading trade publications, and secured high‑value byline opportunities for her clients. These efforts have traditionally required substantial budgets—an obstacle for many early‑stage companies. Recognizing this gap, Ms. Mayer developed a cost‑effective communications model that empowers medical device and biotech startups to gain prominent, authoritative exposure without the prohibitive costs typically associated with industry media.

Her approach democratizes visibility, giving smaller innovators the same opportunity to be heard as established players—an essential contribution in a field where awareness can directly influence investment, adoption, and patient outcomes.